Work

Expression of miR-185 during neural differentiation of induced pluripotent stem cells from patients with 22q11.2 Deletion Syndrome

Year: 2025
Type: conference-paper
Abstract: Background: The 22q11.2 Deletion Syndrome (22q11.2DS) is the most common microdeletion syndrome in humans and it is associated with high rates of neurodevelopmental disorders (NDDs). Literature data revealed downregulation of miR- 185 expression, located in the 22q11.2 region, in the whole blood of patients with 22q11.2DS. Here we analyze miR-185 expression during neural differentiation of induced pluripotent stem cells (iPSCs), derived from patients with 22q11.2DS, and search for miR- 185 potential target genes associated with NDDs. Material and Methods: The expression of miR-185 was assessed by Taqman qRT-PCR using specified Taqman assay for miR-185. miRNet platform was used to elucidate miR- 185 function in NDDs. miR-185 target genes were predicted by using miRDB, mirWalk and TargetScan. The selection of miR-185 target genes related to NDDs was conducted using online available tools GeneTrack, miRNet and Metascape. Results: Decreased expression of miR-185 was detected in iPSCs derived from patients with 22q11.2DS, compared to healthy control. In addition, the expression of miR-185 was significantly downregulated in neurons from patients with 22q11.2DS compared to expression detected in neurons of healthy control. Using online available tools, we selected three potential target genes of this miRNAs related to NDDs - CSMD2, DLG2 and HIC2. Conclusion: Obtained results indicate that miR-185 and it target genes CSMD2, DLG2 and HIC2 could serve as novel therapeutic targets. Future studies are needed to evaluate their relationship and involvement in neurodevelopmental outcome seen in patients with 22q11.2DS.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7028520881
FWCI:
Cites:
Cited by:
Related to: 9